Supplementary methods Identification of early and late EPC A colony of EPC was defined as a central core of round cells with elongated sprouting cells at the periphery. The mononuclear cells were isolated and re-suspended in growth medium (EndoCult liquid medium; StemCell Technologies), and 5 × 106 mononuclear cells were plated in a fibronectin-coated 6-well plateas previous described.1, 2After 4 days, the non-adherent cells were collected and plated onto a fibronectin- coated 24-well plate (1 × 106 cells per well) in triplicate. In the adherent cells, defined as early and late EPC, the expressed VEGF receptor 2 was detected by RT-PCR. Moreover, RT-PCR analysis confirmed the expression of progenitor cell lineage markers, including CD31 and endothelial NO synthase. Measurement of Plasma Indoxyl Sulfate Plasma IS (i.e., combined free and protein-bound IS) were analyzed with ultra performance liquid chromatography (UPLC) system. In brief, samples were deproteinized by the addition of three parts methanol to one part plasma for determination of IS. The free concentrations of IS were measured in plasmaultrafiltrates obtained using Microcon YM-30 separators (Millipore), followed by the same sample preparation and analysis that was done for plasma IS. A UPLC assay using detection at the 280 nm setting of the PDA detector was performed at room temperature on an AglientZorbax XDB-C18 column of 4.6×150mm. Buffer flow was 0.8 mL/min using 10 mMammonia acetate (pH = 4.0) (A) and 100% acetonitrile (B) with a gradient from 82.5%A/17.5%B to 55%A/45%B, over 9 min. Under these conditions, IS appeared at 1.4 min. Standard curves from IS at 0.5, 1, 2.5, 5, and 10 mg/L, processed in the same manner as the serum samples, correlated to the 1 serum samples with average r2 values of 0.999 ± 0.001. Quantitative results were obtained and calculated as concentrations (mg/L). The sensitivity of this assay was 0.225 mg/L for IS. Measurement of Nitric Oxide Production Monolayer cells were grown in six-well plate dishes until 90% confluence and then starved in a serum-free medium for 4 hours. The cells were treated with various concentrations of IS (10-5 to 10-3M), and the supernatants were collected at different time intervals. NO release was determined by measurement of nitrite (NO2−) and nitrate (NO3−) levels using a commercially available Total NO/Nitrite/Nitrate Assay Kit (R&D Systems) according to the manufacturer's instructions. 3 In vitro tube formation assay EPC tube formation assay was performed with an In Vitro Angiogenesis Assay Kit (BD BioCoat angiogenesis System). After cell harvest, 1×104 late EPCs were placed in a matrix solution with EGM-2 MV medium and incubated at 37°C for 6 h. Tubule formation was inspected under an inverted light microscope (×100) with a microscope video system. Tube formation was measured using the BD AttoVision Software System with a number of parameters such as tube length.4 DNA cell cycle For the cell cycle analysis, the cells were trypsinizedand were fixed with 40C methanol for at least 30 min and then stained with 50 ug/ml propidium iodide and 40ug/ml RNase A for 30 min in the dark. Cell cycle distribution was determined by flow cytometric analysis (Becton Dickinson FACScan) and Cell Quest software (Becton Dickinson). All cell cycle distributions represent the mean standard deviation of at nine independent experiments of flow cytometric analysis. 2 3 Supplementary Tables Supplementary Table 1. Primer sequences used in Real time-PCR Gene LC3B LC3A ITGB7 ITGA4 ITGB1 ICAM1 VCAM1 eNOs(mice) NGAL(mice) LC3b (mice) Forward Reward Forward Reward Forward Reward Forward Reward Forward Reward Forward Reward Forward Reward Forward Reward Forward Reward Forward Reward Sequences 5’-GCCGCACCTTCGAACAAA-3’ 5’-TCGTTCTATTATCACCGGGATTTT-3’ 5’-CCGACCGCTGTAAGGAGGTA-3’ 5’-ACCCTTGTAGCGCTCGATGAT-3’ 5’-TGCTTGGACGGCTACTATGGT-3’ 5’-AGTCCTGAAGGCCCCACACT-3’ 5’-CGAACCGATGGCTCCTAGTG-3’ 5’-CACGTCTGGCCGGGATT-3’ 5’-CTTCAGAATTGGATTTGGCTCAT-3’ 5’-TGGTGCAGTTCTGTTCACTTGTG-3’ 5’-GCAGACAGTGACCATCTACAGCTT-3’ 5’-CACCTCGGTCCCTTCTGAGA-3’ 5’-TGGTCAGCCCTTCCTCCAT-3’ 5’-GCTGCCTGCTCCACAGGAT-3’ 5’-CACCAGGAAGAAGACCTTTAAGGA-3’ 5’-CACACGCTTCGCCATCAC-3’ 5’-GCCACTCCATCTTTCCTGTTG-3’ 5’-GAAGAGGCTCCAGATGCTCCTT-3’ 5’-CGTCCTGGACAATACCAAGT-3’ 5’-ATTGCTGTCCCGAATGTCTC-3’ Size (bp) 84 80 102 116 107 80 99 85 84 233 Abbreviations: LC3B=microtubule-associated protein 1 light chain 3 beta LC3A=microtubule-associated protein 1 light chain 3 alpha ITGb7 = integrin, beta 7 ITGa4 = integrin, alpha 7 ITGb1 = integrin, beta 1 ICAM1 = intercellular adhesion molecule 1 VCAM1 = vascular cell adhesion molecule 1 eNOS(NOS3) = nitric oxide synthase 3 (endothelial cell) NGAL= neutrophil gelatinase-associated lipocalin 4 Supplementary Figures Supplementary Fig 1. (A) Flow cytometry analysis of circulating human endothelial progenitor cells (EPCs) (B) Identification of EPC with immunofluorescence microscopy . KDR, kinase domain insert receptor; acLDL, acetylated low-density lipoprotein. (C) Morphology of our early and late human EPCs. Most of the EPC expressed endothelial and hematopoietic stem cell markers, CD31, CD34, KDR, VE-cadherin and eNOs, which are considered critical markers of EPCs. Cells were counterstained with DAPI for the nuclei (blue). Supplementary Fig 2. Organic anion transporter (OAT)1 and OAT3 were identified in neither early nor late EPC.RT-PCR analysisof VEGF receptor 2 (VEGFR2), CD31, endothelial NO synthase (eNOS), mRNA expression. 5 Supplementary Fig 3. Cell cycle progression determined by flow cytometry. The distribution and percentage of cells in the G1and G2/M phases of the cell cycle are indicated. A histogram plot of flow cytometry analysis of control cells shows that after 24 h of 10-3 M IS treatment, cells in the G0/G1 population increased from 66.9% to 75.7% compared to the cells in the control group, whereas the increase in cell population was blunted by anti-oxidative NAC (70.6%). The data shown here are from a representative experiment repeated 9 times with similar results. (*, P < 0.05; # P = not significant, vs. untreated control). 6 Supplementary Fig 4 IS stimulated late EPC showed a up-regulation of LC3b messenger RNA and Relative Quantification blunted by ATO quantified by real -time PCR. 2.5 * 2.0 Control 1.5 IS 10-3M 1.0 IS+ATO 0.1M 0.5 0.0 LC3A LC3B Supplementary Fig 5 a IS significantly decreased expression of p-eNOs in late EPCs at a concentration of 10-3M. (vs. untreated control) 7 Supplementary Fig 5 b Effects of IS and ATO on eNOS, Akt, ERK,, VEGF and HO-1 production in cultured EPCs. Administration of IS on cultured EPCs followed by treatment of ATO significantly upregulatedeNOS activity, but not ERK, AKT, and VEGF. 8 Supplementary Fig 6. An in vitro angiogenesis assay was performed with late EPCs to investigate the effect of IS on EPC neovascularization by ECMatrix gel. The averages of the total area of complete tubes formed were compared using the BD AttoVision Software System. The functional capacity for tube formation of late EPCs was blunted by IS and restored by adding SNP and ATO. However, the recovery capacity of ATO was downregulated by the nitric oxide synthase inhibitor L-NAME. Supplementary Fig 7 Is exacerbated the kidney injury at 3days after ischemic injury. However the kidney function indicator, creatinine was restored after ATO pretreatment. In this study, removing the right kidney allowed assessment of renal functional recovery in the left post-ischemic kidney.5 9 Supplementary Fig 8 I/R AKI animals without IS infusion to evaluate the effect of AST120 (capable of absorbing IS via the intestine) on renal outcome after removal of contralateral kidney. The results showed that mice pretreated with AST 120 exhibited less kidney injury, in terms of NGAL and more number of blood EPCs Reference 1. 2. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, Liu PL, Chen YL, Chen JW. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes. 2007;56:1559-1568 Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW, Lin SJ. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived 10 3. 4. 5. endothelial progenitor cells. Arteriosclerosis, thrombosis, and vascular biology. 2009;29:1179-1184 Guevara I, Iwanejko J, Dembinska-Kiec A, Pankiewicz J, Wanat A, Anna P, Golabek I, Bartus S, Malczewska-Malec M, Szczudlik A. Determination of nitrite/nitrate in human biological material by the simple griess reaction. Clin Chim Acta. 1998;274:177-188 Wu VC, Lo SC, Chen YL, Huang PH, Tsai CT, Liang CJ, Kuo CC, Kuo YS, Lee BC, Wu EL, Lin YH, Sun YY, Lin SL, Chen JW, Lin SJ, Wu KD. Endothelial progenitor cells in primary aldosteronism: A biomarker of severity for aldosterone vasculopathy and prognosis. The Journal of clinical endocrinology and metabolism. 2011;96:3175-3183 Patschan D, Hildebrandt A, Rinneburger J, Wessels JT, Patschan S, Becker JU, Henze E, Kruger A, Muller GA. The hormone melatonin stimulates renoprotective effects of "early outgrowth" endothelial progenitor cells in acute ischemic kidney injury. American journal of physiology. Renal physiology. 2012;302:F1305-1312 11